Datasets:

ruchit2801

/

poq_large

like 0

As I mentioned, demand for our Sapphire and [ Sapphire XC ] Systems remain high.

Does that -- what sort of expectations, I guess, are you building in, in terms of FX or impact on sort of that overall market there?

But sort of what level of spending could be dialed back if the rate case outcome is not in line with what you believe to be a good return on invested capital option?

We continue to be pleased that our customers value the products and services that we're offering, and we plan to continue to focus on providing new and more innovative solutions to our customer base.

Given that advertisers may allocate more budget, both international and domestic advertisers, on CCTV or in [ Roku ], because the advertisers' budgets are relatively limited, so we expect [indiscernible] advertising is affected.

Our total purchase price, which is composed of cash, equity and potential future payments net of a significant tax benefit, will end up in the range of $65 million to $85 million.

And that's -- they're combined with all the other major projects that we've got going on.

For full year 2020, we expect year-over-year revenue growth to be in the range of 22% to 24%.

And the start of the macro perspective for the second half, can you just give us a rough idea, number of horsepower and then sort of how long you expect to be up in the Liard Basin?

The tax incentive financing, may we expect more of that throughout the year?

First of all, on memory, data center demand appears to have remained strong year-to-date.

The biggest change related to synergies is higher-than-estimated amortization of non-cash intangible asset expense of about $10 million.

In 2015, we expect similar performance from Brazil as compared to 2014, if not largely better.

And we are confident that our 2016 revenue growth will be within our targeted range of 16% to 20%.

From a cash flow standpoint, cash flows are anticipated modestly higher than the operating cash flow in fiscal 2014.

We expect these staff reductions to be completed by the end of 2016 with projected expense savings of $50 million for the approximately 75% of the savings to positively impact 2016 results.

These forward-looking statements reflect Peregrine Pharmaceuticals' current views about future events and financial performance.These forward-looking statements are identified by the use of terms and phrases such as believes, expects, plans, anticipates, on target and similar expressions identifying forward-looking statements.

I mean, I think, again, as Chris explained, we've done a very in-depth job with the businesses over the past semester, over the past 6 months and mainly in the second quarter, plant by plant, operation by operation to both shift our portfolio and focus our priorities and resources to our top customers, not addressing again the 17,000 customers the same way we've been doing in the past, focusing on the top one.

We are not talking about complex projects with a lot of robots, et cetera, involved.

We see eventual benefit in sorting out the budget, even if there are funding shortages on a comparative basis with prior expenditure levels, because ITS is a productivity improvement over several engineering responses.

Except as required by law, FB Financial disclaims any obligation to update or revise any forward-looking statements contained in this presentation, whether as a result of new information, future events or otherwise.

We offer these few examples to help illustrate Optum's diversity and commitment to delivering remarkable value for patients and customers.

We expect similar benefits from the refinancing of higher rate debt on 2 of the original 747 -8s delivered to us in 2011.

And this is just to sum it up before we open up for questions here that we saw, I would say, a very strong growth pretty much according to plan.

KCS also announced in November a new capital allocation policy meant to help shareholders understand how the company plans to allocate its cash generated from operations and our targeted leverage ratio going forward.

Well, notifications, I would say, we've been notified in the last month of approximately $20 million of revenue over the 1 year, 1.5 years projects.

Assuming a revenue midpoint of approximately $825 million, we plan to deliver diluted earnings per share of $1.50.

The benefits next year probably will be in excess of about EUR 100 million, and there may be some costs as we close out on those particular initiatives, but the bulk of them have been taken in the December period of last year.

Obviously, the fact that we are screening the film for them, many, many, many weeks in advance is in itself I think a clear indication of our confidence in the movie and the fact that having a movie that will play for many, many, many weeks versus a movie that will be in and out of the marketplace in two weeks is a choice that exhibition gets to make in all of this.

And if that happens, obviously, the expectations for the company will be also positive because we will be one of the major companies helping Moderna to supply the market.

In addition to this, we estimate that the company will receive a tax refund of approximately $83 million in September 2019.

As I've mentioned earlier, our multichannel route to market strategy had a significant impact on our results for the first half and underpins our revenue projections for the balance of FY '19.

We continue to be pleased with the progress of these collaborations and we remain grateful for the opportunity to work closely with Allergan's high quality R&D organization.

I believe you said -- and do you think that that is it for that market or is there still some stuff coming down the pipe?

And then you suggested the addressable market would be probably down next year 2.6 to 2.7.

The outlook last year did not appear very positive due to the abundant amount of Chinese urea stored at the Chinese ports and ready for export.

Of this, $142 million in sustaining capital was 13% higher than the first quarter of 2020, reflecting additional ore reserve development exploration and deferred stripping, in line with our strategy to create improved mining flexibility and ore body confidence.

We exited 2013 with the strongest quarterly organic sales growth for the year at the high end of our targeted range of 5% to 7%.

Looking ahead, our focus for the coming quarters remains on new opportunities for revenue enhancement and expense reduction.

If we look to the effect full year from this capacity, we are very close to what we said originally, that we don't expect a significant full year effect from this.

We plan to make additional strategic promotional and capital investments in both our distribution and retail segments to attract new customers and enhance our programs for consumers.

These forward-looking statements are based on OPI's beliefs and expectations as of today, Friday, April 30, 2021, and actual results may differ materially from those that we project.

Just on the Internet spend line it should go to 5.1 to 5.2 next year.

CBOE's Options Institute has greatly increased its VIX related curricula to keep up with our customer demand and our Annual Risk Management Conference, which will be held next month in Carlsbad, California continues to showcase the evolving state of the art in VIX trading.

In industrial configuration, we have switched off 2 slab-casting machines in order to concentrate operations and increase productivity in other areas, and we have planned another stopover in 5 machines for the same purpose.

We believe that this increase in conversion is a result of our improved user experience and competitive offering of private label products.

While new industry construction could moderate in the U.S. over time, we believe our brand conversions will likely accelerate.

So I think we've said as we look at our coal plants -- and our business is pretty simple.

Our China business added 7 new stores, and the New Market in Wuhan, and the China business is on track to doing the 30 stores we committed to get done in 2012 and good performance coming off of that team.

Joe, back to this $1 billion synergy comment between Dell and VMware and a lot of investors are trying to figure out was incremental, and this was asked in the last week's call, but if you could try to give more detail about why now this is going to be all this incremental opportunities for Dell to sell Vsand and NSX versus a year ago where there was a partnership already with Dell, I think that would be very helpful to better details sort of where you see that moving and sort of what the plans are in place to sort of accelerate that to get to these synergies?

As for interest, the interest rate, we believe it will increase from 0.5% to 1%.

We have some internal numbers, but customers really haven't shared a lot of their ramp plans beyond 2018, and that's -- I don't know, 40-or-so million worth of steppers for us, something like this.

I think the key thing -- well, obviously the key financial goal over all of that period will be to, as Neil has pointed out and I think now as we've all reiterated, is to repay the debt as fast as we possibly can.

And as we mentioned in the last conference call, we see, depending on the wholesale cost, positive margins in the coming years that are not for 2017.

On North American revenues, I believe that the network North American revenues were up about 7% in the quarter.

As Martin said earlier, the AHG shareholders will receive the interim dividend announced today by accepting the offer, which is closing soon.

It will take us a few quarters to do this, but we'll be back in a normal working capital position next year.

Last year, they pulled forward orders for the dirt equipment intentionally, whereas Aerials isn't really in that situation.

Now my next question is, what is the projected date for production to start, if there is one?

You have, I believe, another $100 million of the 11% unsecured that you would wish to take out upon arrival of the ABL, just wanted to confirm that as well and then ask really what sort of flexibility you've retained for another sweeping refinancing between now and 2030, just given the trajectory of the business, it looks like this should not be an 8.5% cost of debt company in 2 or 3 years.

When we believe the timing is appropriate, we will refinance these bonds.

That money is not going away from CaixaBank, it's moving into mutual funds, pension plans, insurance, and part of it is moving into demand deposits, expecting to be reinvested at a later stage.

And then the second factor that I mentioned was around some of the large multiyear contracts that are up for renewal in FY '19.

If we look at the outlook for 2016, we have to point out some important things.

Operationally, to close seven plants including the last Sioux City, to give up sales volume, which is extremely difficult and market share is something that management teams have trouble reconciling.

So based on the timing of our lease-up projections, we're really not anticipating meaningful improvement in our occupancy for the rest of 2014.

Of that, you could think about it as little more than about $95 million is projected to be incremental direct revenue to us.

So regarding income, it was actually better than the plan almost.

If we do, it would be principally directed, as I say, towards bolstering the valuation of Bell Aliant's plans.

During 2011, the operator added a total of 59 newly drilled wells and reentered wells, as well as a third production collection site to complete the EOR project in that Western half of the field.

We'll expand those technology efforts, particularly in guest segmentation and guest targeting.

Is there any, I guess, goal with respect to incremental margins?

Looking on the consolidated income statement, the rental income increased by 2.4%, and property costs increased slightly more than income greatly due to vacated project properties and low initial gross margins in the Slakthusområdet area.

So if you start also really going to the nitty-gritty kind of details, you would expect in a quarter like this that the movement because of interest rate is more than 8%.

And that position will allow us to go all the way through to first oil in the TEN project in Ghana and still have about $1 billion of headroom.

And do you have more of a kind of a target R&D as a percent of sales run rate that you think about when you look forward?

As I mentioned in the last 2 calls, what we are calling emerging markets for ZCL include longer-term opportunities in new market segments for both Underground storage, LNG infrastructure construction and expected this fall, EPA's revisions of the Underground storage tank regulations in the United States.

The automotive industry is seeing a significant impact from the pandemic, and we expect that to affect our revenue in the second quarter as well, likely declining about 40% from Q1.

Based on our current plans, we believe that we have a sufficient funding through the anticipated approval of Amphora for hormone-free birth control in 2020.

A discussion of these and other factors that may affect future results is contained in our most recent form 10-K filed with the SEC and in today's earnings release, both of which are available on our website.

We achieved this record revenue in 2017 while concurrently undertaking some substantial initiatives that we believe will result in long-term growth and increased shareholder value.

And we do have positive expectations for the continued productivity from the MMP Portfolio.

After the new paper is published, we intend to seek partners for this technology.

In the second half, within Material Handling machinery, we expect industrial cranes for power and port applications to remain strong.

We believe 2017 spending will be slightly higher than last year.

I'd be curious to hear where you're expecting the largest drivers of margin expansion relative to Q4 to come from in 2023?

Whilst we have a lot to learn in Spain about dynamic revenue management, we hope to leverage the skills we have in the U.K. and things are working out together.

Before we begin, I'll remind you that the slides presented on this call are available on the Investor Relations section of our website and that our remarks today will include forward-looking statements and that actual results could differ materially from those projections.

We anticipated that our channel partners will be cautious with inventory levels as we move into the winter season.

We believe this new technology will enable new areas of monitoring mission-critical business applications while capturing business intelligence and the end-user experience that will help expand our footprint in the enterprise and the growing wireless service provider space.

On your EBIT walk at the end of your presentation, in terms of price/mix, you're expecting 0, I think, 0.2 [ph] to 0.5 [ph] this year.

Legacy operating income is expected to be around $106 million or up around 11% to 13% versus the fourth quarter of last year.

We remain focused on delivering innovative products, connecting with our customers both in and out of the store and systems and our team members for scale and long-term growth.

I want to take a minute to discuss our outlook for these markets as we move into the second half of the year.

It appears to me that the difference between what we've done and what others have done in the past anyways, is that they were supporting their DTAs, which is the second way you can support them, is by future -- forecast the future taxable earnings.

As we look out into the fourth quarter, we expect Global Rolled Products to be impacted by the strong auto demand for both auto sheet and brazing sheet, the further ramp up of the Davenport auto line; seasonal decline in the packaging bus, which is typical third quarter to fourth quarter.

One is that when you have planned 737 MAX, these are expensive machines, how do you see your lease expenses reacting to that?

Our development spending is expected to be also generally in line with the third quarter.

Our plan is to, of course, install in as many as possible.

For EndoPredict, we anticipate continued improvement in U.S. revenue given the Medicare LCD, which became effective in January and improved reimbursement access in the international markets.